Compound Evidence File
#EC-2026-0337
Trenbolone Enanthate
Filed under Injectable Oils. The bureau holds 145 laboratory returns for this compound from 52 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
52 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Feb 2026 | 28 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Feb 2026 | 9 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Mar 2026 | 1 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Nov 2025 | 11 Feb 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Feb 2026 | 12 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 10.0 | 10.0 | 8 Apr 2026 | 19 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Apr 2026 | 26 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 8 Feb 2026 | 4 Jul 2026 |
| CellupepCASE #VI-2026-0888 | X | 1 | 10.0 | 10.0 | 10.0 | 3 Jul 2025 | 3 Jul 2025 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 20 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 22 Apr 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Apr 2026 | 10 Aug 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Mar 2026 | 25 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 12 Feb 2026 | 4 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Jan 2026 | 16 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Jun 2026 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 15 Feb 2026 | 27 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 9.9 | 8 Mar 2026 | 15 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 24 Feb 2026 | 7 Mar 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 9.9 | 4 Jul 2026 | 3 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 9.9 | 11 Jun 2026 | 26 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Feb 2026 | 14 Mar 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 9.1 | 9.1 | 9.1 | 6 May 2025 | 6 May 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 9.0 | 7.5 | 10.0 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.7 | 6.8 | 9.6 | 23 May 2026 | 23 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 8.5 | 7.6 | 9.4 | 7 May 2025 | 26 Jan 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.5 | 8.5 | 8.5 | 11 Jun 2025 | 11 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.3 | 6.8 | 9.5 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.2 | 7.0 | 10.0 | 21 May 2026 | 21 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 8.0 | 7.9 | 8.0 | 21 May 2026 | 21 May 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 7 | 7.4 | 4.8 | 10.0 | 16 Mar 2025 | 24 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 | 9 Jun 2025 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 7.0 | 7.0 | 7.0 | 17 Dec 2024 | 17 Dec 2024 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 6.7 | 6.7 | 6.7 | 8 Jul 2025 | 8 Jul 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 | 24 Apr 2025 |
| SRY LabsCASE #VI-2026-0657 | X | 11 | 6.5 | 4.9 | 8.7 | 14 Jan 2025 | 21 May 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 | 20 Jun 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 3 | 6.2 | 3.8 | 8.0 | 11 Jun 2025 | 24 May 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.1 | 6.1 | 6.1 | 21 May 2025 | 21 May 2025 |
| LSPLCASE #VI-2026-0523 | X | 4 | 5.8 | 4.6 | 6.9 | 16 Mar 2025 | 24 May 2026 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 5.8 | 5.8 | 5.8 | 3 Jun 2025 | 3 Jun 2025 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 1 | 5.6 | 5.6 | 5.6 | 14 Jan 2025 | 14 Jan 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 5.5 | 5.5 | 5.5 | 24 Apr 2025 | 24 Apr 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 5.4 | 5.4 | 5.4 | 11 Jun 2025 | 11 Jun 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 5.4 | 5.4 | 5.4 | 2 Jul 2025 | 2 Jul 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 5.0 | 5.0 | 5.0 | 3 Jul 2025 | 3 Jul 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 4.8 | 4.8 | 4.8 | 2 Apr 2025 | 2 Apr 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 4.7 | 4.7 | 4.7 | 14 Jan 2025 | 14 Jan 2025 |
| LN PeptidesCASE #VI-2026-0781 | X | 1 | 4.3 | 4.3 | 4.3 | 25 Apr 2025 | 25 Apr 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 1.5 | 1.5 | 1.5 | 20 Jun 2025 | 20 Jun 2025 |
Open any subject to view the batch-level evidence for Trenbolone Enanthate alone.